Published in Curr Drug Targets on May 01, 2010
Systematic review of the concurrent and predictive validity of MRI biomarkers in OA. Osteoarthritis Cartilage (2011) 1.73
Pharmacologic therapy for osteoarthritis--the era of disease modification. Nat Rev Rheumatol (2010) 1.34
Biomarkers for osteoarthritis: current position and steps towards further validation. Best Pract Res Clin Rheumatol (2014) 1.17
Post-traumatic osteoarthritis: from mouse models to clinical trials. Nat Rev Rheumatol (2013) 1.15
Clinical relevance of bone marrow lesions in OA. Nat Rev Rheumatol (2012) 0.91
OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis. Osteoarthritis Cartilage (2015) 0.91
Applications of proteomics to osteoarthritis, a musculoskeletal disease characterized by aging. Front Physiol (2011) 0.83
Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks? Arthritis Res Ther (2016) 0.81
Dendritic spine remodeling following early and late Rac1 inhibition after spinal cord injury: evidence for a pain biomarker. J Neurophysiol (2016) 0.78
Discovery of circulating proteins associated to knee radiographic osteoarthritis. Sci Rep (2017) 0.75
The price of innovation: new estimates of drug development costs. J Health Econ (2003) 23.43
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther (2001) 14.78
Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med (1989) 11.07
Surrogate end points in clinical trials: are we being misled? Ann Intern Med (1996) 9.81
Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiol Aging (1998) 5.05
The Vioxx debacle. Am J Med (2005) 4.58
The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol (1998) 3.75
Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol (2000) 3.63
Combining several screening tests: optimality of the risk score. Biometrics (2002) 3.34
Surrogate endpoints and FDA's accelerated approval process. Health Aff (Millwood) (2005) 3.14
Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage (2006) 3.10
Fit-for-purpose method development and validation for successful biomarker measurement. Pharm Res (2006) 2.96
Change in joint space width: hyaline articular cartilage loss or alteration in meniscus? Arthritis Rheum (2006) 2.80
Statistical evaluation of biomarkers as surrogate endpoints: a literature review. Stat Med (2006) 2.79
Biomarkers and surrogate markers: an FDA perspective. NeuroRx (2004) 2.20
Process map proposal for the validation of genomic biomarkers. Pharmacogenomics (2006) 2.08
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. Control Clin Trials (2001) 2.06
Are surrogate markers adequate to assess cardiovascular disease drugs? JAMA (1999) 1.98
Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol (2001) 1.85
Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs. Clin Pharmacol Ther (2007) 1.83
Strategic paths for biomarker qualification. Toxicology (2008) 1.45
Imaging in osteoarthritis. Rheum Dis Clin North Am (2008) 1.42
Biomarker method validation in anticancer drug development. Br J Pharmacol (2007) 1.41
The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints. Stat Methods Med Res (2007) 1.41
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. J Rheumatol (2007) 1.35
The Biomarkers Consortium: on the critical path of drug discovery. Clin Pharmacol Ther (2008) 1.23
Pitfalls in the accurate measurement of joint space narrowing in semiflexed, anteroposterior radiographic imaging of the knee. Arthritis Rheum (2004) 1.22
An approach to the validation of markers for use in AIDS clinical trials. Clin Infect Dis (1997) 1.17
Biomarker qualification pilot process at the US Food and Drug Administration. AAPS J (2007) 1.17
OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. J Rheumatol (2007) 1.16
Overview of biomarkers and surrogate endpoints in drug development. Dis Markers (2002) 1.15
Surrogate endpoints: a basis for a rational approach. Eur J Clin Pharmacol (1992) 1.06
The contribution of clinical pharmacology surrogates and models to drug development--a critical appraisal. Br J Clin Pharmacol (1997) 1.00
Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future. Pharmacol Rev (2007) 0.97
A users guide to measurement in medicine. Osteoarthritis Cartilage (2006) 0.96
Imaging biomarkers as surrogate endpoints for drug development. Eur J Nucl Med Mol Imaging (2006) 0.94
Joint National Cancer Institute-Food and Drug Administration workshop on research strategies, study designs, and statistical approaches to biomarker validation for cancer diagnosis and detection. Cancer Epidemiol Biomarkers Prev (2006) 0.90
Evaluating surrogate markers. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.87
Is knee radiography useful for studying the efficacy of a disease-modifying osteoarthritis drug in humans? Rheum Dis Clin North Am (2003) 0.87
NIH-FDA Conference: Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications. Abstracts. Dis Markers (1998) 0.85
Statistical validation of surrogate endpoints: is bone density a valid surrogate for fracture? J Musculoskelet Neuronal Interact (2004) 0.84
The Biomarkers Consortium: public and private sectors working in partnership to improve the public health. Oncologist (2007) 0.82
NCI's National Biospecimen Network: too early or too late? J Natl Cancer Inst (2005) 0.77
Principles of use of surrogate markers and endpoints. Maturitas (2004) 0.77
An inauspicious start for the US National Biospecimen Network. J Clin Invest (2004) 0.77
Statistical considerations in combining biomarkers for disease classification. Dis Markers (2004) 0.76
Expanded screening for HIV in the United States--an analysis of cost-effectiveness. N Engl J Med (2005) 8.49
Incidental meniscal findings on knee MRI in middle-aged and elderly persons. N Engl J Med (2008) 8.40
The survival benefits of AIDS treatment in the United States. J Infect Dis (2006) 7.08
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol (2007) 6.65
Surgery versus physical therapy for a meniscal tear and osteoarthritis. N Engl J Med (2013) 6.08
The lifetime cost of current human immunodeficiency virus care in the United States. Med Care (2006) 5.87
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. N Engl J Med (2006) 5.62
Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr (2009) 5.40
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa. Clin Infect Dis (2008) 5.14
Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am (2004) 4.42
Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am (2003) 4.38
When to start antiretroviral therapy in resource-limited settings. Ann Intern Med (2009) 4.31
Correlation of the development of knee pain with enlarging bone marrow lesions on magnetic resonance imaging. Arthritis Rheum (2007) 4.06
Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis (2010) 3.96
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS (2010) 3.93
HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin Infect Dis (2009) 3.89
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr (2006) 3.39
Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am (2003) 3.33
Meniscal tear in knees without surgery and the development of radiographic osteoarthritis among middle-aged and elderly persons: The Multicenter Osteoarthritis Study. Arthritis Rheum (2009) 3.19
Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med (2013) 3.10
Fixed-flexion radiography of the knee provides reproducible joint space width measurements in osteoarthritis. Eur Radiol (2004) 3.10
Association of hospital and surgeon volume of total hip replacement with functional status and satisfaction three years following surgery. Arthritis Rheum (2003) 2.98
Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. J Infect Dis (2008) 2.96
Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department. J Acquir Immune Defic Syndr (2007) 2.91
Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum (2006) 2.81
Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis (2007) 2.81
Revising expectations from rapid HIV tests in the emergency department. Ann Intern Med (2008) 2.74
Articular cartilage in the knee: current MR imaging techniques and applications in clinical practice and research. Radiographics (2011) 2.70
Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am (2005) 2.67
The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis. Arthritis Rheum (2005) 2.54
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med (2003) 2.48
Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. Clin Infect Dis (2005) 2.47
Optimizing resource allocation in United States AIDS drug assistance programs. Clin Infect Dis (2006) 2.45
Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis. AIDS (2005) 2.39
Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis (2012) 2.38
Spinal stenosis prevalence and association with symptoms: the Framingham Study. Spine J (2009) 2.32
Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. S Afr Med J (2008) 2.30
Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing. Arch Intern Med (2002) 2.30
Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis (2010) 2.28
HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies. J Acquir Immune Defic Syndr (2009) 2.24
Relationship of meniscal damage, meniscal extrusion, malalignment, and joint laxity to subsequent cartilage loss in osteoarthritic knees. Arthritis Rheum (2008) 2.23
Longitudinal performance evaluation and validation of fixed-flexion radiography of the knee for detection of joint space loss. Arthritis Rheum (2007) 2.23
HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme. Antivir Ther (2009) 2.18
Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging. Arthritis Rheum (2011) 2.17
Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum (2006) 2.17
Relation of hand enthesophytes with knee enthesopathy: is osteoarthritis related to a systemic enthesopathy? J Rheumatol (2011) 2.10
Early knee osteoarthritis is evident one year following anterior cruciate ligament reconstruction: a magnetic resonance imaging evaluation. Arthritis Rheumatol (2015) 2.06
Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire. PLoS One (2010) 2.05
Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis (2009) 2.05
Tibiofemoral joint osteoarthritis: risk factors for MR-depicted fast cartilage loss over a 30-month period in the multicenter osteoarthritis study. Radiology (2009) 1.95
Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med (2012) 1.94
Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. Med Decis Making (2002) 1.94
Structural factors associated with malalignment in knee osteoarthritis: the Boston osteoarthritis knee study. J Rheumatol (2005) 1.93
Imaging of synovitis in osteoarthritis: current status and outlook. Semin Arthritis Rheum (2011) 1.86
Estimating the burden of total knee replacement in the United States. J Bone Joint Surg Am (2013) 1.84
Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters. J Virol (2010) 1.81
The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clin Infect Dis (2012) 1.80
Low levels of vitamin D and worsening of knee osteoarthritis: results of two longitudinal studies. Arthritis Rheum (2007) 1.79
Association of hospital and surgeon procedure volume with patient-centered outcomes of total knee replacement in a population-based cohort of patients age 65 years and older. Arthritis Rheum (2007) 1.78
Refusing HIV testing in an urgent care setting: results from the "Think HIV" program. AIDS Patient Care STDS (2006) 1.76
Outcomes after virologic failure of first-line ART in South Africa. AIDS (2010) 1.74
Cost-effectiveness of genotype testing for primary resistance in Brazil. J Acquir Immune Defic Syndr (2015) 1.73
Spondylolysis and spondylolisthesis: prevalence and association with low back pain in the adult community-based population. Spine (Phila Pa 1976) (2009) 1.71
Knee buckling: prevalence, risk factors, and associated limitations in function. Ann Intern Med (2007) 1.71
Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol (2014) 1.69
Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin Infect Dis (2003) 1.69
Effectiveness of clinical pathways for total knee and total hip arthroplasty: literature review. J Arthroplasty (2003) 1.68
The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa. J Acquir Immune Defic Syndr (2011) 1.67
Twelve-year risk of revision after primary total hip replacement in the U.S. Medicare population. J Bone Joint Surg Am (2012) 1.67
Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count. S Afr Med J (2011) 1.65
Bone marrow lesions in the knee are associated with increased local bone density. Arthritis Rheum (2005) 1.64
Facet joint osteoarthritis and low back pain in the community-based population. Spine (Phila Pa 1976) (2008) 1.64
Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann Rheum Dis (2011) 1.63
The lifetime medical cost savings from preventing HIV in the United States. Med Care (2015) 1.61
Outcomes of open carpal tunnel release at a minimum of ten years. J Bone Joint Surg Am (2013) 1.61
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV. AIDS (2008) 1.59
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness. J Acquir Immune Defic Syndr (2010) 1.57
Survival following total hip replacement. J Bone Joint Surg Am (2005) 1.57
Emergency provider attitudes and barriers to universal HIV testing in the emergency department. J Emerg Med (2009) 1.57
Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial. Clin Infect Dis (2007) 1.57
Meniscus pathology, osteoarthritis and the treatment controversy. Nat Rev Rheumatol (2012) 1.57
Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med (2005) 1.56
Frequent HIV testing among participants of a routine HIV testing program. Virulence (2010) 1.53
Quadriceps strength and the risk of cartilage loss and symptom progression in knee osteoarthritis. Arthritis Rheum (2009) 1.50
Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age. AIDS (2015) 1.49
Defining radiographic incidence and progression of knee osteoarthritis: suggested modifications of the Kellgren and Lawrence scale. Ann Rheum Dis (2011) 1.48
Routine HIV screening in France: clinical impact and cost-effectiveness. PLoS One (2010) 1.46
Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review. Pharmacoeconomics (2010) 1.46
Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. J Virol (2011) 1.45
The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men. Clin Infect Dis (2007) 1.43
A randomized controlled trial of an internal family systems-based psychotherapeutic intervention on outcomes in rheumatoid arthritis: a proof-of-concept study. J Rheumatol (2013) 1.43
Choice of hospital for revision total hip replacement. J Bone Joint Surg Am (2010) 1.43
The role of varus and valgus alignment in the initial development of knee cartilage damage by MRI: the MOST study. Ann Rheum Dis (2012) 1.42
The cost-effectiveness of total joint arthroplasty: a systematic review of published literature. Best Pract Res Clin Rheumatol (2012) 1.42
Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. Am J Public Health (2005) 1.41
MRI features of cystic lesions around the knee. Knee (2008) 1.41
The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS (2012) 1.40
Instrument for measuring angles in spine radiographs. Orthopedics (2005) 1.40